qualifications for glp 1 Nutritional priorities to support GLP-1 therapy obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society How Employers Can Optimize Benefits

When combined, patients may experience: Markedly reduced food intake, potentially leading to inadequate nutrition Difficulty consuming sufficient calories to maintain healthy body function Increased risk of nutrient deficiencies if dietary intake becomes severely restricted Challenges in maintaining adequate hydration Cardiovascular considerations also warrant attention

"Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground." September 2025

Heart Failure: GLP-1 agonists reduce the risk of heart failure and increase survival rates in patients with existing heart failure

Biocare is companion nutrition for active GLP-1 use built around appetite suppression, protein needs, and digestive comfort.* Biocare2 is for the chapter after: maintaining results once you stop or taper the medication, with ingredients that help control hunger and promote healthy metabolism.* See the full Biocare vs

How much do GLP-1 medications cost under the Medicare GLP-1 Bridge program

Combining different treatment modalities (including lifestyle interventions, pharmacotherapies and bariatric surgery) may support people to achieve individualised long-term goals, maximise health benefits and improve quality of life